Terms: = Kidney tumors AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
22 results:
1. SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.
Choong OK; Jakobsson R; Bergdahl AG; Brunet S; Kärmander A; Waldenström J; Arvidsson Y; Altiparmak G; Nilsson JA; Karlsson J; Nyström K; Johansson ME
PLoS One; 2023; 18(1):e0279578. PubMed ID: 36595529
[TBL] [Abstract] [Full Text] [Related]
2. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Schmidt AL; Tucker MD; Bakouny Z; Labaki C; Hsu CY; Shyr Y; Armstrong AJ; Beer TM; Bijjula RR; Bilen MA; Connell CF; Dawsey SJ; Faller B; Gao X; Gartrell BA; Gill D; Gulati S; Halabi S; Hwang C; Joshi M; Khaki AR; Menon H; Morris MJ; Puc M; Russell KB; Shah NJ; Sharifi N; Shaya J; Schweizer MT; Steinharter J; Wulff-Burchfield EM; Xu W; Zhu J; Mishra S; Grivas P; Rini BI; Warner JL; Zhang T; Choueiri TK; Gupta S; McKay RR
JAMA Netw Open; 2021 Nov; 4(11):e2134330. PubMed ID: 34767021
[TBL] [Abstract] [Full Text] [Related]
3. Management of Patients With Glucocorticoid-Related Diseases and COVID-19.
Chifu I; Detomas M; Dischinger U; Kimpel O; Megerle F; Hahner S; Fassnacht M; Altieri B
Front Endocrinol (Lausanne); 2021; 12():705214. PubMed ID: 34594302
[TBL] [Abstract] [Full Text] [Related]
4. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
Ramirez Alvarez C; Kee C; Sharma AK; Thomas L; Schmidt FI; Stanifer ML; Boulant S; Herrmann C
PLoS Pathog; 2021 Jun; 17(6):e1009687. PubMed ID: 34181691
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
[No Abstract] [Full Text] [Related]
6. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
[TBL] [Abstract] [Full Text] [Related]
7. Targetable gene fusions and aberrations in genitourinary oncology.
Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
[TBL] [Abstract] [Full Text] [Related]
8. An investigation into the molecular basis of cancer comorbidities in coronavirus infection.
Facchiano A; Facchiano F; Facchiano A
FEBS Open Bio; 2020 Nov; 10(11):2363-2374. PubMed ID: 32970391
[TBL] [Abstract] [Full Text] [Related]
9. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.
Klein EA; Li J; Milinovich A; Schold JD; Sharifi N; Kattan MW; Jehi L
J Urol; 2021 Feb; 205(2):441-443. PubMed ID: 32897764
[TBL] [Abstract] [Full Text] [Related]
10. Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.
Kerslake R; Hall M; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Mol Med; 2020 Sep; 46(3):949-956. PubMed ID: 32705281
[TBL] [Abstract] [Full Text] [Related]
11. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.
Chang P; Bing Z; Tian J; Zhang J; Li X; Ge L; Ling J; Yang K; Li Y
Medicine (Baltimore); 2018 Nov; 97(44):e12679. PubMed ID: 30383629
[TBL] [Abstract] [Full Text] [Related]
13. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K
Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117
[TBL] [Abstract] [Full Text] [Related]
14. Intrafocal heterogeneity of ERG protein expression and gene fusion pattern in prostate cancer.
Suh JH; Park JH; Lee C; Moon KC
Prostate; 2017 Oct; 77(14):1438-1445. PubMed ID: 28845585
[TBL] [Abstract] [Full Text] [Related]
15. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract] [Full Text] [Related]
16. Frequency of PTEN alterations, tmprss2-ERG fusion and their association in prostate cancer.
Fallahabadi ZR; Noori Daloii MR; Mahdian R; Behjati F; Shokrgozar MA; Abolhasani M; Asgari M; Shahrokh H
Gene; 2016 Jan; 575(2 Pt 3):755-60. PubMed ID: 26424596
[TBL] [Abstract] [Full Text] [Related]
17. The tmprss2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.
Chatterjee P; Choudhary GS; Alswillah T; Xiong X; Heston WD; Magi-Galluzzi C; Zhang J; Klein EA; Almasan A
Mol Cancer Ther; 2015 Aug; 14(8):1896-906. PubMed ID: 26026052
[TBL] [Abstract] [Full Text] [Related]
18. Somatic alterations contributing to metastasis of a castration-resistant prostate cancer.
Nickerson ML; Im KM; Misner KJ; Tan W; Lou H; Gold B; Wells DW; Bravo HC; Fredrikson KM; Harkins TT; Milos P; Zbar B; Linehan WM; Yeager M; Andresson T; Dean M; Bova GS
Hum Mutat; 2013 Sep; 34(9):1231-41. PubMed ID: 23636849
[TBL] [Abstract] [Full Text] [Related]
19. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
20. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.
Ricketts CJ; Morris MR; Gentle D; Brown M; Wake N; Woodward ER; Clarke N; Latif F; Maher ER
Epigenetics; 2012 Mar; 7(3):278-90. PubMed ID: 22430804
[TBL] [Abstract] [Full Text] [Related]
[Next]
